Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs iShares China Large-Cap ETF (FXI) Price & Performance

Dolby Laboratories, Inc.Trade
iShares China Large-Cap ETFTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs iShares China Large-Cap ETF — how do they compare? Dolby Laboratories, Inc. trades at $48.49 (market cap $4.59B), while iShares China Large-Cap ETF trades at $34.14. The key difference: Dolby Laboratories, Inc. pays a 2.91% dividend while iShares China Large-Cap ETF pays none, and iShares China Large-Cap ETF is trading nearer its 52-week high, Dolby Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.

DLBFXI
Market Cap
$4.59B
Sector
Industrials
52-Week High
$76.79$41.75
52-Week Low
$48.51$31.59
Enterprise Value
$4.04B
Dividend Yield
2.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

Dolby Laboratories (DLB) trades at $49.36, down 0.88% on the day, with a bearish technical outlook. The company maintains strong fundamentals, including a P/E of 19.59, a net income margin of 17.85%, and consistent earnings beats in recent quarters. Recent news highlights include its role in powering immersive audio for the FIFA World Cup 2026 coverage and recognition as a top supplier by General Motors.

The stock presents a value opportunity given its discount to the analyst consensus price target of $87.50, but faces near-term headwinds from bearish technical signals and cyclical end-market exposure. Upside potential hinges on continued licensing growth and execution, while risks include market sentiment and competitive pressures.

iShares China Large-Cap ETF

FXI trades at $33.44, down slightly (-0.12%) on the day, with technical indicators showing mixed signals between bullish moving averages and neutral oscillators. The ETF benefits from China's aggressive AI and EV investments, including a $295 billion AI infrastructure plan and 30% NEV fleet target by 2030. Recent manufacturing rebounds and strong export data provide fundamental support, though geopolitical tensions with the US pose headwinds.

Outlook remains cautiously optimistic given China's tech investment surge and manufacturing recovery. Key opportunities include exposure to AI hardware exports and domestic EV growth, while risks center on US-China trade restrictions and potential valuation pressures. The ETF offers diversified China large-cap access but requires monitoring of geopolitical developments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB

About iShares China Large-Cap ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.

Read more on FXI